Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Human monocytes cultured on adherent IgG produce a specific IL-1 inhibitor that functions as a receptor antagonist (IL-1ra). This molecular has been purified, sequenced, cloned as a cDNA, and expressed in Escherichia coli. Recombinant IL-1ra has 17,000 mol wt and binds to IL-1 receptors on T lymphocytes, synovial cells, and chondrocytes with an affinity nearly equal to that of IL-1. These studies have examined some biological properties of purified recombinant human IL-1ra. This protein exhibits a dose-responsive inhibition of Il-1 alpha and Il-1 beta augmentation of PHA-induced murine thymocyte proliferation. The recombinant IL-1ra also blocks IL-1 alpha and IL-1 beta stimulation of PGE2 production in human synovial cells and rabbit articular chondrocytes, and of collagenase production by the synovial cells. A 50% inhibition of these IL-1-induced biological responses requires amounts of IL-1ra up to 100-fold in excess of the amounts of IL-1 alpha or IL-1 beta present. IL-1ra may play an important role in normal physiology or in pathophysiological states by functioning as a natural IL-1 receptor antagonist in the cell microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Interleukin-1 and Its Biologically Related Cytokines
Dinarello, C. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,151
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
Self-citationEisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088
Self-citationCytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
Arend, W. P., & Dayer, J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330302 · Cited by 949
Self-citationProduction of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells.
Dayer, J. M., Krane, S. M., Russell, R. G., & Robinson, D. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.945 · Cited by 550
Cytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M. (1986) · Science · doi:10.1126/science.3086977 · Cited by 529
A urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
Arend, W. P., Joslin, F. G., & Massoni, R. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.3868 · Cited by 322
Self-citationTwo high-affinity interleukin 1 receptors represent separate gene products.
Chizzonite, R., Truitt, T., Kilian, P. L., Stern, A. S., Nunes, P., Parker, K. P., Kaffka, K. L., Chua, A. O., Lugg, D. K., & Gubler, U. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8029 · Cited by 264
Cited by
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Relationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288
“It antagonizes the proinflammatory activity of IL-1 (20, 21) and may improve insulin sensitivity in rodents (22).”
BackgroundINTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Self-citationTumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
Self-citationOpal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
Ohlsson, K., Björk, P., Bergenfeldt, M., Hageman, R., & Thompson, R. C. (1990) · Nature · doi:10.1038/348550a0 · Cited by 853
Self-citationInterleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist
Dinarello, C. A. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043005 · Cited by 761
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
Self-citationThe balance between IL-1 and IL-1Ra in disease
Arend, W. P. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00020-5 · Cited by 721
Self-citationInflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Self-citationChung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
Arend, W. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115453 · Cited by 595
Self-citationVezzani, A., Conti, M., De Luigi, A., Ravizza, T., Moneta, D., Marchesi, F., & De Simoni, M. G. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05054.1999 · Cited by 584
Osteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 563
Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?
Verri, W. A., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 542
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Dripps, D. J., Brandhuber, B. J., Thompson, R. C., & Eisenberg, S. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99230-6 · Cited by 452
Self-citationPalomo, J., Dietrich, D., Martin, P., Palmer, G., & Gabay, C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.06.017 · Cited by 447
Regulation of myeloid development and function by colony stimulating factors
Barreda, D. (2004) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2003.09.010 · Cited by 402
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A., & Thorbecke, G. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2918 · Cited by 399
Dinarello, C. A. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1177 · Cited by 397
Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 395
Interleukin‐1α and Interleukin‐1 β in Preterm and Term Human Parturition
ROMERO, R., MAZOR, M., BRANDT, F., SEPULVEDA, W., AVILA, C., COTTON, D. B., & DINARELLO, C. A. (1992) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1992.tb00737.x · Cited by 392
Frisbie, D., Ghivizzani, S., Robbins, P., Evans, C., & McIlwraith, C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301608 · Cited by 385
Pereira, B. J. G., Shapiro, L., King, A. J., Falagas, M. E., Strom, J. A., & Dinarello, C. A. (1994) · Kidney International · doi:10.1038/ki.1994.117 · Cited by 384
Anti-Cytokine Therapy for Rheumatoid Arthritis
Maini, R. N., & Taylor, P. C. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.207 · Cited by 376
Caron, J. P., Fernandes, J. C., Martel‐Pelletier, J., Tardif, G., Mineau, F., Geng, C., & Pelletier, J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390914 · Cited by 366
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7375 · Cited by 360
Kitazawa, R., Kimble, R. B., Vannice, J. L., Kung, V. T., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117606 · Cited by 336
Gomez, R., Ghezzi, F., Romero, R., Muñoz, H., Tolosa, J. E., & Rojas, I. (1995) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30286-0 · Cited by 334
Jimi, E., Nakamura, I., Duong, L. T., Ikebe, T., Takahashi, N., Rodan, G. A., & Suda, T. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4320 · Cited by 333
Cominelli, F., Nast, C. C., Clark, B. D., Schindler, R., Lierena, R., Eysselein, V. E., Thompson, R. C., & Dinarello, C. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114799 · Cited by 333
Self-citationDifferent receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.
Kent, S., Bluthe, R. M., Dantzer, R., Hardwick, A. J., Kelley, K. W., Rothwell, N. J., & Vannice, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9117 · Cited by 322
Vannier, E., Miller, L. C., & Dinarello, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4076 · Cited by 321
Gomez, R., Romero, R., Edwin, S. S., & David, C. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70347-0 · Cited by 312
IL-36R ligands are potent regulators of dendritic and T cells
Vigne, S., Palmer, G., Lamacchia, C., Martin, P., Talabot-Ayer, D., Rodriguez, E., Ronchi, F., Sallusto, F., Dinh, H., Sims, J. E., et al. (2011) · Blood · doi:10.1182/blood-2011-05-356873 · Cited by 308
McIntyre, K. W., Stepan, G. J., Kolinsky, K. D., Benjamin, W. R., Plocinski, J. M., Kaffka, K. L., Campen, C. A., Chizzonite, R. A., & Kilian, P. L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.931 · Cited by 289
Matrix Metalloproteinases: The Clue to Intervertebral Disc Degeneration?
Goupille, P., Jayson, M. I. V., Valat, J.-P., & Freemont, A. J. (1998) · Spine · doi:10.1097/00007632-199807150-00021 · Cited by 287
Alternatively activated macrophages; a double-edged sword in allergic asthma
Abdelaziz, M. H., Abdelwahab, S. F., Wan, J., Cai, W., Huixuan, W., Jianjun, C., Kumar, K. D., Vasudevan, A., Sadek, A., Su, Z., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02251-w · Cited by 287
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., & Pacifici, R. (1995) · Endocrinology · doi:10.1210/endo.136.7.7789332 · Cited by 273
Interleukin‐6 and interleukin‐1 receptor antagonist in acute stroke
Beamer, N. B., Coull, B. M., Clark, W. M., Hazel, J. S., & Silberger, J. R. (1995) · Annals of Neurology · doi:10.1002/ana.410370614 · Cited by 231
Romero, R., & Tartakovsky, B. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)80035-4 · Cited by 214
CLEC5A is critical for dengue virus–induced inflammasome activation in human macrophages
Wu, M.-F., Chen, S.-T., Yang, A.-H., Lin, W.-W., Lin, Y.-L., Chen, N.-J., Tsai, I.-S., Li, L., & Hsieh, S.-L. (2013) · Blood · doi:10.1182/blood-2012-05-430090 · Cited by 210
Fever: Causes and consequences
Moltz, H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80009-0 · Cited by 183
Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity
Osborn, O., Brownell, S. E., Sanchez-Alavez, M., Salomon, D., Gram, H., & Bartfai, T. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.004 · Cited by 160
“Over 100-fold higher levels of IL-1Ra over IL-1b are necessary to functionally inhibit the effects of IL-1 on target cells [35] in pharmacological settings for example during IL-1Ra therapy in inflammation.”
Rambaldi, A., Torcia, M., Bettoni, S., Vannier, E., Barbui, T., Shaw, A., Dinarello, C., & Cozzolino, F. (1991) · Blood · doi:10.1182/blood.v78.12.3248.3248 · Cited by 129
Tachida, Y., Nakagawa, K., Saito, T., Saido, T. C., Honda, T., Saito, Y., Murayama, S., Endo, T., Sakaguchi, G., Kato, A., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05127.x · Cited by 86
van der Poll, T., Van Zee, K. J., Endert, E., Coyle, S. M., Stiles, D. M., Pribble, J. P., Catalano, M. A., Moldawer, L. L., & Lowry, S. F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7714108 · Cited by 85
Carroll, J. A., Striebel, J. F., Race, B., Phillips, K., & Chesebro, B. (2015) · Journal of Virology · doi:10.1128/jvi.02952-14 · Cited by 63
Metadata
- Authors
- Arend, W. P., Welgus, H. G., Thompson, R. C., & Eisenberg, S. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1990-05-01
- Volume
- 85
- Issue
- 5
- Pages
- 1694-1697
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2073598149
- Cited by
- 581
- References
- 20
- FWCI
- 19.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.